Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00111176 · ClinicalTrials.gov registry record · NA

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

A NA study of Thoracic Aortic Aneurysm, sponsored by Cook Group Incorporated.

Completed
Registry status
NA
Development phase
260
Enrollment target
20
Study locations

NCT00111176 is a NA study of Thoracic Aortic Aneurysm that has completed, run by Cook Group Incorporated. The registered enrollment target is 260 participants, below the 875-participant average among 7 other Thoracic Aortic Aneurysm trials with a reported enrollment target (70% lower). The trial reports 20 study locations across 16 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00111176, a NA study of Thoracic Aortic Aneurysm, has completed, sponsored by Cook Group Incorporated.

COMPLETED
Registry status
NA
Development phase
260 participants
Enrollment target
20
Study locations

Study Summary

The STARZ-TX2 trial (Study of Thoracic Aortic Aneurysm Repair with the Zenith TX2(R) TAA \[Thoracic Aortic Aneurysm\] Endovascular Graft) is a clinical trial approved by the United States Food and Drug Administration (FDA) to study the safety and effectiveness of the Zenith TX2 TAA Endovascular Graft in the treatment of thoracic aortic aneurysms / ulcers.

Conditions Studied

Thoracic Aortic Aneurysm

Interventions

  • PROCEDURE Surgical
  • DEVICE Endovascular repair

Study Locations (20)

Arizona

  • Banner Desert Medical Center - Mesa
  • Arizona Heart Institute - Phoenix

California

  • University of California, San Francisco - San Francisco
  • Stanford University Hospital and Clinics - Stanford

Florida

  • University of Florida - Gainesville
  • Mayo Clinic - Jacksonville

Maryland

  • University of Maryland Medical Center - Baltimore
  • Union Memorial Hospital - Baltimore

Colorado

  • Swedish Medical Center - Englewood

District of Columbia

  • Washington Hospital Center - Washington D.C.

Georgia

  • Emory University - Atlanta

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2004-03
Est. Completion 2013-05
Phase NA

Sponsor

Cook Group Incorporated

31 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00111176

The ClinicalTrials.gov registry entry for NCT00111176 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 875-participant average among 7 other Thoracic Aortic Aneurysm trials with a reported enrollment target (70% lower). The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thoracic Aortic Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which Surgical is the first listed.

NCT00111176 reports 20 study locations spanning 16 distinct geographic areas - top geographies include Arizona, California, Florida.

Frequently Asked Questions

What is clinical trial NCT00111176 about?

NCT00111176 is a clinical study titled "STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft". The STARZ-TX2 trial (Study of Thoracic Aortic Aneurysm Repair with the Zenith TX2(R) TAA \[Thoracic Aortic Aneurysm\] Endovascular Graft) is a clinical trial approved by the United States Food and Drug Administration (FDA) to study the safety and effectiveness of the Zenith TX2 TAA Endovascular Graf...

What is the current status of trial NCT00111176?

This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2004-03. Estimated completion is 2013-05.

What conditions does trial NCT00111176 study?

This clinical trial studies the following conditions: Thoracic Aortic Aneurysm.

What interventions are being tested in trial NCT00111176?

The interventions under investigation include: Surgical (PROCEDURE), Endovascular repair (DEVICE).

Who is sponsoring clinical trial NCT00111176?

This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00111176 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Thoracic Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Thoracic Aortic Aneurysm

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.